Evidence map›Paper›PMID 34962729›Full record

ArticleRevista de la Facultad de Ciencias Medicas (Cordoba, Argentina)2021

Incidence of COVID-19 after pulmonary function tests: a retrospective cohort study.

Esteban Javier Wainstein, Hector Jose Peroni, Bruno Leonel Ferreyro, Maria Ines Staneloni, Miriam Gabriela Marcos, Alejandro Wolfgor, Valeria Ines Aliperti, Horacio Matias Castro

Open access · diamondAbstract read
In one paragraph

Article in Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Esteban Javier WainsteinSecci´´´ón de Neumonologia. Hospital Italiano de Buenos Aires. Argentina. . esteban.wainstein@hospitalitaliano.org.ar.
Hector Jose PeroniMedico Especialista en Medicina Interna y Neumonologia. . jose.peroni@hospitalitaliano.org.ar.
Bruno Leonel FerreyroInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.. bruno.ferreyro@hospitalitaliano.edu.ar.
Maria Ines StaneloniSección de Infectologia. Hospital Italiano de Buenos Aires. Argentina.. maria.staneloni@hospitalitaliano.org.ar.
Miriam Gabriela MarcosSección de Neumonologia. Hospital Italiano de Buenos Aires Argentina. . miriam.marcos@hospitalitaliano.org.ar.
Alejandro WolfgorSección de Neumonologia. Hospital Italiano de Buenos Aires Argentina. . alejando.wolfgor@hospitalitaliano.org.ar.
Valeria Ines AlipertiSección Epidemiología del Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Argentina.. valeria.aliperti@hospitalitaliano.org.ar.
Horacio Matias CastroSección de Neumonologia. Hospital Italiano de Buenos Aires. Argentina. . matias.castro@hospitalitaliano.org.ar.
Hospital Italiano de Buenos Aires · ARHospital de Especialidades · MXUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIt has been proposed that exposure to pulmonary function tests (PFT) could be associated with a higher risk of viral transmission. The risk of the Coronavirus Disease 2019 (COVID-19) transmission after performing PFT is unknown. We aimed to assess the incidence  of COVID-19 after a PFT at an academic teaching facility in Buenos Aires, Argentina. MATERIALS AND

methodsWe conducted a retrospective cohort study including all consecutive adult patients that performed PFT between April 1, 2020 and September 30, 2020. Patients with prior COVID-19 were excluded. We defined a 15-day time window to  ascertain PFT related COVID-19. The primary outcome was ascertained by consulting a national database, which has information on all patients with nasopharyngeal swabs for SARS-CoV-2 in Argentina.

resultsWe included 278 patients who performed a PFT. Fifty percent were women, the mean age was 54 years (SD 18), and the main comorbidities were obesity (31%), smoking (31%), hypertension (29%), and chronic lung disease (28%). The main indication for performing PFT was anesthetic preoperative risk assessment. Swabs were collected from 27 patients (10%). Twenty-two swabs (8%) were taken according to surgical protocols; five swabs (2%) were taken due to clinical suspicion of COVID-19, with only one testing positive. The cumulative incidence of COVID-19 after PFT was 0.36% (95% CI 0.01-20%). None of the technicians developed symptomatic disease.

conclusionGiven the right setting and strict adherence to international recommendations, the SARS-CoV-2 infection after having a PFT appears to be low, which follows that these procedures can be performed safely for both patients and staff.

Indexed as

COVID-19AdultFemaleHumansIncidenceLungMiddle AgedRetrospective StudiesSARS-CoV-2aerosol spraybiosecurityCOVID-19Respiratory Function TestsSARS CoV-2

Identifiers

PMID34962729
PMCPMC8765371
OpenAlexW4200092227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.